Inhalable Antibodies for SARS-CoV-2
Inhalable Antibodies for SARS-CoV-2
Internal Medicine
Revealing genetic and cellular mechanisms of Crohn’s disease
New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients
Liquid biopsy for the win in cancer
Twist Bioscience launches NGS methylation detection system for cancer analysis and epigenetic studies
Reducing the risk of bacteremia
New biomarkers can predict risk of patients dying from bacteremia
Brain biomarkers for depression and trauma
Combining machine learning and EEG may have identified an imaging biomarker for better treating PTSD and MDD
Grading non-alcoholic steatohepatitis
Median Technologies teams up with UC San Diego on diagnosing liver fibrosis severity in NASH patients
Go with your gut (microbiome)
Study details results on a new method for treating immunotherapy-resistant melanoma patients
Three old mice, see how they run
USC’s ‘exercise protein’ doubles running capacity and extends healthy lifespans in older mice
Cholesterol may be key to new Alzheimer’s and diabetes therapies
University of Arizona researcher looks beyond traditional causes to find novel therapies
A new option for EPI
AzurRx completes enrollment in Phase 2 clinical trial of MS1819 in combination with PERT to treat cystic fibrosis patients with severe exocrine pancreatic insufficiency
A new way to treat gingivitis
Positive top-line Phase 2 results for AMY-101 in adults with periodontal inflammation and gingivitis
